$3.00 sure should be a realistic number. OWCP hit $3.23 after they were found to be listed on the Cannabis ETF and a PR about the Wall Street Conference that most of us already knew about...
Efficacy Test Results for the first product that's to launch by Quarter 2 should be "epic" in comparison.
$3.00 should be easy. Should. Again, if it doesn't hit $3.00 on that news... This is a messed up world.
AXIM ran from 0.395 to $19.80 on news for a product that won't launch until 2018 or 2019.